Home Newsletters Cell Therapy News A Comparison of Chimeric Antigen Receptors Containing CD28 versus 4–1BB Costimulatory Domains

A Comparison of Chimeric Antigen Receptors Containing CD28 versus 4–1BB Costimulatory Domains

0
Scientists provide an overview of T cell costimulation by CD28 and 4-1BB and, using the available preclinical and clinical data, compare the efficacy and toxicity profiles associated with CARs containing either costimulatory domain.
[Nature Reviews Clinical Oncology]

Sorry, but the selected Zotpress account can't be found.

Abstract
Exit mobile version